journal article·2025-08Open access

An Artificial Peroxynitrite‐Resistant Superoxide Dismutase for Acute Kidney Injury Alleviation

Fengxian Zhang, Ping Gao, Min Qi, Junjie Hu, Xiuxun Wu, Cao Li, Zechao Zhuang, Zhenpeng Qiu, Ziqiang Xu

Small· Volume 21· Issue 33

Abstract

Abstract Manganese superoxide dismutase (Mn‐SOD) is the most common natural antioxidant enzyme that defends cells against oxidative stress. However, it is intrinsically vulnerable to nitration by peroxynitrite (ONOO − ) to result in accumulation of reactive oxygen species and inducement of acute kidney injury (AKI). Designing Mn‐SOD mimics that are both active and resistant to ONOO − is essential for advancing artificial enzymes and broadening the application of enzymatic catalytic therapies. Herein, an artificial manganese‐based single‐atom nanozymes (Mn‐O 5 /CN SAzyme) featuring square‐pyramidal Mn‐O 5 active sites and abundant hydroxyl groups is presented. Mn‐O 5 /CN SAzyme demonstrates excellent biocompatibility, superior SOD‐like activity, and tolerance to ONOO − , positioning it as a promising artificial enzyme mimics for alleviating AKI. Theoretical calculations suggest that the square‐pyramidal Mn‐O 5 coordination in Mn‐O 5 /CN SAzyme enhances its SOD‐like activity and ONOO − resistance. Mn‐O 5 /CN SAzyme has high antioxidant efficacy toward HK‐2 cells. It significantly reduces renal oxidative stress and inflammation in AKI mice, without any side effects. Mechanistically, Mn‐O 5 /CN SAzyme alleviates AKI by suppressing the pro‐inflammatory cytokine cascade driven by the NOD‐like receptor protein 3 (NLRP3)/caspase‐1/gasdermin D pathway. This study highlights the crucial role of the Mn‐O 5 coordination structure in enhancing SOD‐like activity and ONOO − resistance, presenting a novel strategy for treating inflammatory diseases.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Advanced Nanomaterials in Catalysis · Neurological Complications and Syndromes · Vanadium and Halogenation Chemistry

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Hubei Province Key Laboratory of Biotechnology of Chinese Traditional Medicine College of Health Sciences and Engineering School of Materials Science & Engineering Hubei University Wuhan 430062 P. R. China

College of Health Sciences and Engineering Hubei University Wuhan 430062 P. R. China

School of Pharmacy Hubei University of Chinese Medicine Wuhan 430065 P. R. China

Wuhan Children's Hospital Tongji Medical College Huazhong University of Science and Technology Wuhan 430015 P. R. China

School of Life and Health Sciences Hubei University of Technology Wuhan 430068 P. R. China

Department of Chemistry Tsinghua University Beijing 100084 P. R. China

Department of Chemical Engineering Columbia University New York 10027 USA

Center of Traditional Chinese Medicine Modernization for Liver Diseases Hubei University of Chinese Medicine Wuhan 430065 P. R. China

Hubei Key Laboratory of Resources and Chemistry of Chinese Medicine Hubei University of Chinese Medicine Wuhan 430065 P. R. China

Funding

National Natural Science Foundation of China

References (39)

Show source-provided references
1. 10.1016/S0021-9258(18)63504-510.1016/S0021-9258(18)63504-5 ↗
2. 10.1038/ng1295-37610.1038/ng1295-376 ↗
3. 10.1021/acs.chemrev.5b0040710.1021/acs.chemrev.5b00407 ↗
4. 10.1021/acs.chemrev.7b0056810.1021/acs.chemrev.7b00568 ↗
5. 10.1021/acs.biochem.6b0004510.1021/acs.biochem.6b00045 ↗
6. 10.1039/C7MT00348J10.1039/C7MT00348J ↗
7. 10.1084/jem.192.12.173110.1084/jem.192.12.1731 ↗
8. 10.1002/adfm.20221469310.1002/adfm.202214693 ↗
9. 10.1021/acsnano.3c0500510.1021/acsnano.3c05005 ↗
10. 10.1016/j.nantod.2021.10126910.1016/j.nantod.2021.101269 ↗
11. 10.1002/adhm.20240163010.1002/adhm.202401630 ↗
12. 10.1021/acsnano.3c0437810.1021/acsnano.3c04378 ↗
13. 10.1002/adfm.20231211610.1002/adfm.202312116 ↗
14. 10.1038/s41467-024-51022-410.1038/s41467-024-51022-4 ↗
15. 10.1002/advs.20230691110.1002/advs.202306911 ↗
16. 10.1038/s41467-023-42889-w10.1038/s41467-023-42889-w ↗
17. 10.1038/s41467-023-35828-210.1038/s41467-023-35828-2 ↗
18. 10.1016/j.nantod.2023.10176810.1016/j.nantod.2023.101768 ↗
19. 10.1016/j.nantod.2023.10180910.1016/j.nantod.2023.101809 ↗
20. 10.1021/jo048518z10.1021/jo048518z ↗
21. 10.1016/j.redox.2017.09.00910.1016/j.redox.2017.09.009 ↗
22. 10.1016/j.cej.2023.14704810.1016/j.cej.2023.147048 ↗
23. 10.1016/j.cej.2020.12737110.1016/j.cej.2020.127371 ↗
24. 10.1016/j.freeradbiomed.2006.04.02810.1016/j.freeradbiomed.2006.04.028 ↗
25. 10.1002/adhm.20230169110.1002/adhm.202301691 ↗
26. 10.1038/s41467-024-53047-110.1038/s41467-024-53047-1 ↗
27. 10.1002/advs.20247010110.1002/advs.202470101 ↗
28. 10.3390/ijms2012301110.3390/ijms20123011 ↗
29. 10.1016/j.freeradbiomed.2022.11.02910.1016/j.freeradbiomed.2022.11.029 ↗
30. 10.1161/CIRCULATIONAHA.109.91609810.1161/CIRCULATIONAHA.109.916098 ↗
31. 10.1152/physrev.00005.202210.1152/physrev.00005.2022 ↗
32. 10.1021/acs.chemrev.7b0056810.1021/acs.chemrev.7b00568 ↗
33. 10.1016/j.pain.2013.07.03210.1016/j.pain.2013.07.032 ↗
34. 10.2337/db10-038610.2337/db10-0386 ↗
35. 10.1152/physrev.00005.202210.1152/physrev.00005.2022 ↗
36. 10.1186/s13045-023-01512-710.1186/s13045-023-01512-7 ↗
37. 10.1016/j.tibs.2016.10.00410.1016/j.tibs.2016.10.004 ↗
38. 10.1016/j.phrs.2021.10603310.1016/j.phrs.2021.106033 ↗
39. 10.1021/bi00011a00810.1021/bi00011a008 ↗